Intravitreal injections to prevent blindness due to wet type age-related macular degeneration

Authors

  • Elina C. Pérez Molina Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • Francisco Rodríguez Denis Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba
  • María Elena Guillen Bravo Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Keywords:

macular degeneration, intravitreal injections, treatment outcome

Downloads

Download data is not yet available.

Author Biographies

Elina C. Pérez Molina, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Medicina General Integral y Oftalmología. Máster en Longevidad Satisfactoria. Profesora Instructora de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Francisco Rodríguez Denis, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Medicina General Integral. Especialista de II Grado en Oftalmología. Profesor Auxiliar de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

María Elena Guillen Bravo, Hospital Clínico Quirúrgico “Arnaldo Milián Castro”, Santa Clara, Villa Clara, Cuba

Especialista de I Grado en Medicina General Integral y en Oftalmología. Profesora Instructora de la Universidad de Ciencias Médicas de Villa Clara “Dr. Serafín Ruiz de Zárate Ruiz”.

Downloads

How to Cite

1.
Pérez Molina EC, Rodríguez Denis F, Guillen Bravo ME. Intravitreal injections to prevent blindness due to wet type age-related macular degeneration. Acta Méd Centro [Internet]. 2012 Jul. 13 [cited 2025 Jul. 1];6(3):87-9. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/750

Issue

Vol. 6 No. 3 (2012): July-September

Section

Comunications

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).